Related Experiment Videos
Gastroesophageal reflux disease.
1University of Washington.
The Medical Clinics of North America
|July 1, 1991
Summary
Gastroesophageal reflux disease (GERD) affects 10% of adults, causing heartburn and potential esophageal damage. While treatments offer partial relief, surgery or omeprazole may be necessary for resistant cases and preventing Barrett's esophagus.
Area of Science:
- Gastroenterology
- Digestive Health
Background:
- Gastroesophageal reflux disease (GERD) affects approximately 10% of the adult population.
- GERD often presents with frequent heartburn and can be associated with hiatal hernias and lower esophageal sphincter (LES) dysfunction.
- Chronic acid reflux can lead to significant esophageal mucosal damage, potentially progressing to Barrett's esophagus, a premalignant condition.
Purpose of the Study:
- To review the current understanding of GERD, its complications, and treatment options.
- To highlight the limitations of existing therapies and the role of newer agents and surgical interventions.
Main Methods:
- Review of existing literature on GERD pathophysiology, clinical manifestations, and treatment efficacy.
- Analysis of the role of H2-antagonists, adjunctive agents, omeprazole, and surgical interventions in managing GERD.
Main Results:
- H2-antagonists provide only partial relief for many GERD patients.
- Adjunctive agents may improve healing of erosive esophagitis but have limitations due to side effects and cost.
- Omeprazole offers temporary healing for resistant GERD, and surgery is highly successful in well-selected patients.
Conclusions:
- GERD is a chronic condition with a high relapse rate, necessitating maintenance therapy.
- Current treatment options have limitations, underscoring the need for effective management strategies.
- Surgical intervention and short-term omeprazole use represent viable options for refractory GERD and preventing complications like Barrett's esophagus.